DE2603890A1 - Diuretika - Google Patents

Diuretika

Info

Publication number
DE2603890A1
DE2603890A1 DE2603890*[A DE2603890A DE2603890A1 DE 2603890 A1 DE2603890 A1 DE 2603890A1 DE 2603890 A DE2603890 A DE 2603890A DE 2603890 A1 DE2603890 A1 DE 2603890A1
Authority
DE
Germany
Prior art keywords
acid
phenoxyacetic acid
group
thienyl
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE2603890*[A
Other languages
German (de)
English (en)
Inventor
Jun Edward Jethro Cragoe
Jun Otto William Woltersdorf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2603890A1 publication Critical patent/DE2603890A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2603890*[A 1975-02-03 1976-02-02 Diuretika Withdrawn DE2603890A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54659075A 1975-02-03 1975-02-03

Publications (1)

Publication Number Publication Date
DE2603890A1 true DE2603890A1 (de) 1976-08-05

Family

ID=24181101

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2603890*[A Withdrawn DE2603890A1 (de) 1975-02-03 1976-02-02 Diuretika

Country Status (8)

Country Link
AU (1) AU507494B2 (enExample)
BE (1) BE838170A (enExample)
CA (1) CA1075155A (enExample)
DE (1) DE2603890A1 (enExample)
FR (1) FR2299025A1 (enExample)
GB (1) GB1501592A (enExample)
NL (1) NL7600500A (enExample)
ZA (1) ZA76565B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239771A (en) 1977-08-04 1980-12-16 Albert Rolland S.A. Water-soluble salts of tienilic acid
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3275160D1 (en) * 1982-01-04 1987-02-26 Karl H Beyer Hyperuretic agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239771A (en) 1977-08-04 1980-12-16 Albert Rolland S.A. Water-soluble salts of tienilic acid
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Also Published As

Publication number Publication date
NL7600500A (nl) 1976-08-05
BE838170A (fr) 1976-08-02
FR2299025A1 (fr) 1976-08-27
FR2299025B1 (enExample) 1980-06-20
GB1501592A (en) 1978-02-15
AU507494B2 (en) 1980-02-14
CA1075155A (en) 1980-04-08
AU1061176A (en) 1977-08-04
ZA76565B (en) 1977-09-28

Similar Documents

Publication Publication Date Title
DE3503435C2 (enExample)
DE3709621A1 (de) Therapeutisches mittel
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
DE69003213T2 (de) Imidazol-Derivate als Histamin-H3-Agonisten.
DE3212736A1 (de) Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE2624558A1 (de) Arzneimittel mit analgetischer wirkung
DE2947624A1 (de) Beta, gamma -dihydropolyprenylalkohol und diesen enthaltendes blutdrucksenkendes arzneimittel
DE2154245C3 (de) 3-Hydrazino-6-(2-hydroxypropylamino)-pyridazinderivate, Verfahren zu ihrer Herstellung und sie enthaltendes pharmazeutisches Präparat
EP0207397A2 (de) Dihydropyridin Kombinationspräparat
EP0317855B1 (de) Pharmazeutische Präparate
DE2221758C2 (de) Yohimbinderivat, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE3035688C2 (enExample)
DE2603890A1 (de) Diuretika
EP0027268A2 (de) Chinazolin-Derivate, Verfahren und Zwischenprodukte zu deren Herstellung, Arzneimittel enthaltend solche Chinazolin-Derivate und deren pharmazeutische Verwendung
DE2428639A1 (de) Therapeutische mittel
DE1963317A1 (de) Chemische Verfahren und Produkte
EP0314984A2 (de) Verwendung von 2-Pyrimidinyl-1-piperazin-Derivaten
DE2322561A1 (de) Trisubstituierte imidazole
DE2755017C2 (enExample)
DE2615694A1 (de) Pharmazeutische zusammensetzungen
DE2748794C2 (de) Malonylharnstoffkomplexe, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2460304C2 (de) 1-n-Propyl-4-phthalimido-piperidin-2,6-dion, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
DE2448428A1 (de) Diuretische mittel
DE2029510B2 (de) Dibenzofuranderivate und deren pharmazeutisch verträgliche Säureadditionssalze sowie Verfahren zu deren Herstellung und Arzneimittel mit einem Gehalt dieser Verbindungen

Legal Events

Date Code Title Description
8141 Disposal/no request for examination